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Abstract: Deoxynojirimycin (dNM) is a specific and reversible inhibitor of the trimming ac-
tions of glucosidase I and II in the rough endoplasmic reticulum. The importance of the ef-
fects of dNM on the replication of West Nile (sarafend - glycosylated) and West Nile
(Wengler - nonglycosylated) viruses were studied. It was found that dNM treatment in-
crease the molecular weights of the E and prM proteins in both virus strains without affec-
ting the yields of the virus. The intracellular transport of the E protein from the rough en-
doplasmic reticulum to Golgi apparatus was not affected despite the change in molecular
weights. It would appear that the prevention of removal of glucose molecules by dNM did
not affected the maturation of E protein or the virus.
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INTROD UCTION
The envelope (E) protein molecules of flavivirus have a role in the attachment and en-
try of the virus (Collins and Porter field, 1985). Despite the role of the E protein, evidence
have shown that some mature viruses have glycosylated envelope (E) proteins but are absent
in other viruses (Wengler et al, 1985; Wright, 1982). Little is known about the significance of
glycosylation in the process of maturation of viruses. Over the past decade, there has been
wide-spread use of inhibitors of N-linked oligosaccharide processing to study their effects
on viral assembly, maturation and infectivity (Gruters et al, 1987; Kang and Elbein, 1983; Pal
et al, 1989; Pan et al, 1983; Romero et al, 1983: Schwarz et al, 1976).
Deoxynojirimycin (dNM) is an antibiotic which inhibits early glycosylation process. It is
specific and reversible and act on the trimming actions of glucosidase I and I in the rough
endoplasmic reticulum (RER). The two naturally occurring forms of West Nile (WN) virus
i.e. the glycosylated Sarafend strain and the unglycosylated Wengler strain, provided a very
good model to study the significance of the glycosylation process since both can be cultivated
in similar host cell system. Any discrepancies due to differences in host system which might
give rise to variation in the ability to produce mature glycoprotein could be eliminated.
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The WN(Sarafend) and WN(Wengler) virus-infected cells were exposed to dNM at ap-
propriate concentrations under optimum conditions throughout the post-infection period. The
aspects investigated were the yields of the virus, production of virus-specified glycoproteins
and the intracellular transportation of the E protein.
MATERIALS AND METHODS
Cells and viruses: Vero cells is a continuous cell line first isolated by Dr Y Yasumura at
Chiba University, Japan from the kidney cells of African green monkey. The cells were
grown to confluency in Medium 199 containing 5% foetal calf serum and maintained after in-
fection in Eagle's minimum essential medium (MEM) containing 0.1% bovine serum albumin.
The two strains of WN virus used were WN (Sarafend) and the WN (Wengler). The WN
(Sarafend) was from Professor E G Westaway, Australia and the WN (Wengler) was from
professor G Wengler, Germany.
Drug treatment during cell infection: The drug, deoxynojirimycin. HCL (dNM, Sigma,
USA) was in powder form packed in lOmg quantity. Deoxynojirimycin was easily dissolved in
PBS to make up a working solution of lOmM.
For continuous drug treatment on cell monolayer, drug-supplemented MEMwas added
after infection and incubated at 37°C. The infection procedure was done on a confluent
monolayer grown in 25cn! flask (Falcon, USA).
Harvesting of intracellular and extracellular virus: The extracellular virus was harvested
by transfering the culture medium to sterile centrifuge tubes and centrifuged at 1,000 rpm
for 1 minute to remove the cell debris. The supernatant was then dispensed into sterile glass
ampoules. The glass ampoules were frozen in a mixture of absolute ethanol and dry ice and
stored at -70°C until assayed.
After the removal of the culture medium for the extracellular virus, 2ml of MEM was
added. The flask was left horizontally in -70°C freezer for 15 minutes. The frozen cells were
quickly thawed under tap water. The freezing and thawing steps were repeated for another
two more times in order to detach and break up the cells, to release the intracellular virus.
Cell debris was spun down and the supernatant aliquoted into glass ampoules as mentioned
above. The virus titers were obtained by plaque assay.
Radioactive labelling with 3H-mannose: Confluent monolayers of Vero cells grown in 25
en? tissue culture flasks were infected. Drug supplemented MEMwas added to the infected
cells after the 1 hour adsorption period.
To label the virus-specified glycoproteins with 3H-mannose,the infected monolayer was
exposed to medium deficient of glucose for 2 hours and subsequently replaced with labeling
medium containing 40/iCi/ml of 3H-mannose for 6 hours. All the media above contained the
dNM to the final concentration of 2.5mM and 5mM.A mock-infected control and an infected
control without drug treatment were incubated similarly as above.
Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE): The 12%
polyacrylamide gels used were the Laemmli gel system (1970). Twenty-five [A of each labell-
ed sample were used for each lane. Prior to loading, the sample was mixed with 5 {A of
cocktail containing dithioerytritol and bromophenol blue and boiled for 1 minute.
Indirect immunofluorescence microscopy: The cells were grown on coverslips in 24 -well
plates (Falcon, USA). The cell monlayers were infected with WN (Sarafend) and WN
(Wengler) when they reached 75% confluency. The cells were fixed with cold methanol for 10 minutes
before rinsing in cold PBS. The processing for immunofluorescence staining was as describ-
ed previously by Westaway and Goodman (1987).
Indirect immunofluorescence with single labelling using anti-envelope serum was car-
ried out for WN (Sarafend) virus at a series of time intervals (4 hour-intervals upto 20 hours
post infection). As for WN (Wengler) virus the timings were 32, 48 and 64 hours post infec-
tion. Double labelling were done at 20 hours post infection and 48 hours post infection for
WN(Sarafend) and WN (Wengler) viruses respectively.
The antisera used were anti-virus envelope protein (Dr Vincent Duebel, Pasteur In-
stitute, France), anti-Golgi complex (Dr Paul Gleeson, Monash University, Australia) and the
concanavalin A (Vector Laboratory, USA). The concanavalin A was used as a tag for en-
doplasmic reticulum membrane and was a gift from Dr Hong Wan Jin, IMCB, Singapore.
RESULTS
Extracellular and intracellular virus yields: The results are tabulated in Tables 1 and 2.
Only small differences in virus titres were discernible for WN (Sarafend) virus (Table 1) and
WN(Wengler) virus (Table 2). From the results, it could be seen that generally, in the WN
(Sarafend) virus infections, the intracellular virus titers were higher than the extracellular
virus titers. However for the WN (Wengler) virus, the reverse was true. A closer examina-
tion of the date showed that virus titers varied by approximately 1.5 to 5 times between the
drug-treated and untreated samples for the WN (Sarafend) virus infections and a difference
of 1.8 times for WN (Wengler) virus infections. These small difference were insignificant and
Table l･ Virus titres from drug-treated and untreated West
Nile (Sarafend) virus-infected cells.
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Table 2･ Virus titres from drug-treated and untreated
west Nile (Wengler) virus-infected cells.




Intracellular　　　･ 18 × 106　　　　　× 106
2.0×106　　　　　　　　　　　　･8×105
Extracellular　　　･ 4 × 107　　　　　　× 107
2.7×107　　　　　　　　　　　　2.0×108
hence showed that the drug had no effect on the infectivity and final maturation of the
viruses.
Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) of virus-specified
glycoproteins labelled with 3H-mannose: Since dNM inhibits the early step in the glycosylation
pathway, further experiments were carried out to examine the effects of the drag on the
virus-specified glycoproteins. The experiments used 3H-mannoseas it is more specific since
only the glycoprotein side chains were labeled.
From the autoradiograph (Fig. 1), the E and the precursor membrane (prM) proteins
were heavily glycosylated and appeared as a broad smear. It was observed that the E and
the prM glycoprotein bands in the drug-treated samples showed higher molecular weights
(MW) compared with the untreated samples. This effect of the drug was observed for both
WN(Sarafend) and WN (Wengler) viruses infections.
For the WN (Sarafend) virus, the MW of the E protein band from the drag-treated
samples in lanes 2 and 3 (Fig. 1) were found to be approximately 60.95 kd to 61.66 kd respec-
tively. The E protein of the untreated infected control had a MWof 58.20 kd (Lane 4). This
showed that dNM increased the MW of E protein by about 2 to 3 kd. The prM protein
bands from the WN (Sarafend) virus infections were also affected by the drag. The MWof
the drag-treated samples was increased from 21. 38 kd (untreated-Lane 4) to 21. 63 kd (Lane
2) and 22.13 kd (Lane 3). This slight differences in MWof PrM (about 1 kd) is quite signifi-
cant since the prM is a small protein.
It was observed that the intensities of the E and prM glycoprotein bands in the WN
(Wengler) virus samples decrease due to the drug treatment. This effects being more severe
in the sample treated with dNM at the concentration of 2.5 mM (Fig. 1, Lane 5). Similar in-
crease in MWs of E and prM glycoproteins were observed in the drag-treated samples as










Fig. 1 Autoradiography of SDS-Page of cell lysates from West Nile virus-infected Vero cells labeled
with 3H-mannose.
Laneトthe molecular weight markers were a 【14C】 methylated mixture consisting of myosin (200 kd),
phosphorylase b (97.4 kd), bovine serum albumin (69 kd), ovalbumine (46 kd), carbonic
anhydrase (30 kd) and lysozyme (14･3 kd)･
Lane 2-the West Nile [(WN) (Sarafend)] virus-infected sample treated with 2･5mM of dNM･
Lane 3-the WN (Sarafend) virus者infected sample treated with 5mM of dNM･
Lane 4 -the untreated WN (Sarafend) virus者infected control sample･
Lane 5-the WN (Wengler) virus-infected sample treated with 2.5mM of dNM.
Lane 6-the WN (Wengler) virus血fected sample treated with 5mM of dNM･
Lane 7-the untreated WN (Wengler) virus-infected control sample･
Lane 8-the untreated and uninfected control sample.
In the autoradiograph, only the structural proteins such as the envelope (E) proteins, precursor mem-
brane (prM) proteins and p32 proteins are seen･ The p32 protein bands are only found in the WN (Sara･
fend) virus-infected samples･ Close circles denote the viral proteins excluding the E proteins (indicated
by open circle).
Indirect immunofluoresence: The study on the effects of dNM on intracellular transport
of E protein in WN virus replication was carried out using indirect immunofluorescence. The
subcellular localisation of E protein was first examined using anti-envelope serum. To
visualise the distribution of the E protein in the RER and the Golgi complex, rhodamine-con-
jugated concanavalin A (Con A) and anti-Golgi serum were used as markers for the respec-
tive compartments.
The location of E protein was similar to the other flaviviruses as described by Ng and
group (1983) and Westaway and Goodman (1987). There was a fluorescent rim at the
perinuclear region which became more intense as the infection progressed (not shown). The
fluorescence radiated from the boundary of the nucleus and spread in a polar fashion into the
cytoplasm. With dNM treatment, there was no change in the pattern and intensity of
fluorescence (not shown). These observations were consistent for both strains of WN virus
and agreed with the reported works.
Double labelling with anti-envelope serum and concanavalin A: In order to investigate in
dNM affect the glycosylation pathway or intracellular transport of the E protein in WN (Sara-
fend) and WN (Wengler) virus-infected cells, the E proteins were first co-localised with the
RER via double labelling immunofluorescence. In the double-labelling immunofluorescence,
the anti-E serum was conjugated with fluorescein isothiocyanate (FITC) while the Con A was
conjugated with rhodamine.
The cells were infected with West Nile (Sarafend) virus for 20 hours and reacted with
anti-envelope serum and Con A (Fig. 2). The fluorescence staining with anti-envelope serum
was most intense at the perinuclear region (Fig. 2a) and radiated out into the cytoplasm in a
reticular pattern. With the rhodamine-Con A staining (Fig. 2b), the fluorescence pattern was
very similar to the anti-envelope reaction. When the infected cells were treated with either 2.5 mM
or 5 mM of dNM, the fluorescence patterns did not show any significant changes (Fig. 2c
andd).
Similarly, when WN (Wengler) virus was used in the infection, the fluorescence pat-
terns after 48 hours of infection was comparable with the WN (Sarafend) infection (Fig. 3a
and b). The dragalso did not alter the localisation of the envelope protein in the endoplasmic
reticulum (Fig. 3c and d).
Double labelling with anti-envelope and anti-Golgi complex sera: Since the dNM affects
the early glycosidases actions, it was of interest to observe if these unprocessed E proteins
would be transported from the endoplasmic reticulum to the Golgi complex. Double labelling
wasperformed using anti-envelope and anti-Golgi complex sera under the same conditions as
the above. The results showed that for both WN viruses infections (without dNM treatment),
the E protein was transported to the Golgi complex (see Fig. 4a, b and 5a, b). There were
coincidence in the fluorescence staining patterns between the anti-envelope and the anti-Golgi
complex reactions. Once again the dNM did not showed any drastic changes in the






























































Fig. 3　Double indirect immunofluorescence of West Nile (Wengler) virus町infected Vero cells reacted
with anti-envelope serum and concanavalin A.
The cells were infected for 48 hours and stained with anti-envelope serum and Con A林The drug-treated
infected cultures were exposed to the dNM at either 2.5 mM or 5 mM immediately after infection for
hours. Magnification of all figures is 1000 times.
Infected cells not treated with dNM: (a) Very intense network of fluorescence is seen around the
pennuclear region. More `speckled'fluorescence pattern is seen in the cytoplasm. The intensity of the
fluorescence decreases from the perinuclear area to the peripheral region, (b) the intense fluorescence
from labelling with rhodamine conjugated Con A is shown. Intense fluorescence is observed over the en-
tire cytoplasm with the intensity higher at juxtanucleus position林The coincidence of the fluorescence pat-
tern from (a) and (b) indicated that the E proteins in the Wset Nile (Wengler) virus-infected cells are also
localised in the ER.
Infected cells treated with dNM: Again there was no difference in the intensities of the fluorescence after
treatment with either 2.5 mM or 5 mM of dNM. (c) The fluorescence pattern obtained is similar to (a) ex-
cept that the cells have more cytoplasmic extensions(filapodia). The intense particulate fluorescence en-
compasses the cells in a polar fashion with higher intensities around the perinuclei regions, (d) The
bright fluorescence pattern resulting from staining with rhodamine Con A appears similar to (c)･ Thus















































Fig. 4 Double indirect immunofluorescence of West Nile (Sarafend) virus-infected vero cells reacted
with anti-envelope and anti-Golgi sera･
The treatment of the infected cells were similar to Fig. 2 except that the cells were stained with anti･
envelope and anti-Golgi sera. The conjugate used were FITC and Texas red respectively･ Magnification
of all figures is 1000 times.
Infected cells not treated with dNM: (a) A reticular network of fluorescence spread over the entire
cytoplasm, with higher intensity at the perinuclear region, (b) The staining using anti-Golgi serum
hibit less bright仙Iorescence pattern when compared to (a). The fine filaments of伽orescence encom者
pass the unclear, with some filaments extending into the cytoplasm.
Infected cells treated with dNM: The staining patterns and intensities of the fluorescence were similar for
both treatment at 2･5 mM and 5 mM. (c) A reticulate network radiating from an intense point
fluorescence at one side of the nucleus is observed. Some speckles are observed near the peripheral
region, (b) The polar extension of the filamentous and 'speckled'fluorescence patterns are also observed





































Fig. 5　Double indirect immunofluorescence of West Nile (Wengler) virus-infected Vero cells reacted
with anti-envelope and anti-Golgi sera.
The infected cells were treated similarly as in figure 3 except that staining were done using anti-envelo-
pe and anti-Golgi sera. Magnification of all figure is 1000 times.
Infected cells not treated with dNM: The particulate fluorescence pattern is distributed throughout the
cytoplasm, (b) The dim `speckled'pattern of the fluorescence extends from the perinuclear region to仇e
cytoplasm. The fluorescence seem to be slightly polar. The patterns of (a) and (b) appear to be similar.
Infected cells treated with dNM: There was again no difference in the staining intensities between the two
dNM concentrations, (c) Intense filamentous network of fluorescence is seen concentrated around the
pennuclear region and extends in a polar fashion into the cytoplasm･ The intensity of fluorescence
decreases at the cell periphery･ Some granular specks of fluorescence are seen at the peripheral region･
(d) The perinuclear reticular fluorescence pattern of the Golgi complex is observed with Texas red stain-
ing. The intensity of the fluorescence remains greatest at the boundary of the nucleus.
The patterns from (a) to (d) are similar, thus dNM treatment does not affect the distribution of E




The significance of glycosylation in the infectivity and maturation process of viruses is
not known. In an attempt to study the importance of glycosylation in flavivirus, two WN
viruses known to have the glycosylated and nonglycosylated E proteins in mature virions
were chosen. The two viruses were the WN (Sarafend) and WN (Wengler). West Nile
(Wengler) virus was established by Wengler and colleagues (1985) to have nonglycosylated E
proteins in the extracellular virus from nucleotide sequence analysis. It was found that the
membrane-associated protein did not contain an Asn-X-Ser/Thr sequence which would allow
addition of N-linked carbohydrated chains in this protein. The intracellular E protein is
however glycosylated (V. Sreenivasan, personnal communication).
Deoxynojirimycin (dNM) and antibiotic known to inhibit at the very early stage of
glycosylation was used in this study. The dNM prevents trimming actions of the glycosidases
in the RER (Fuhrmann et al, 1985). In addition, dNM showed little toxicity in vitro and in
vivo (Gruters et al, 1987). The effects of inhibiting protein glycosylation have been reported
to either lead to an increases in susceptibility of the nonglycosylated protein to proteolytic
cleavage, inefficient intracellular transport of the protein to the cell surface or inhibition of
virus assembly and infectivity (Sim, 1990). This approach of using inhibitor of glycosylation
to study the repication process of viruses has the advantage of allowing conclusions to be
made about the roles of sugars during synthesis and maturation of glycoproteins.
Analysis of the experimental results showed that dNM does not affect the infectivity
and final maturation of both the WN viruses (Tables 1 and 2). The titers obtained from the
drug-treated WN(Sarafend) and WN (Wengler) virus-infected cells were similar to the titers
for their respective untreated infected cells. The presence of the dNM did not prevent virus
release. This result is consistent with that obtained in the infection with vesicular stomatitis
virus, influenza virus and fowl plaque virus in the presence of dNM (Burke et al, 1984;
Romero et al, 1983).
The dNM treatment did increase the molecular weights of the E and prM proteins as
seen in the 3H-mannoselabelling (Fig. 1). However, this increase in molecular weights did
not affect the maturation process of these viruses as shown in Table 1. The E proteins of the
viruses have been reported to be important in attachment and recognition of host cell recep-
tors (Collins and Porterfield, 1985). The non-removal of glucose residues from the E proteins
of WNviruses after dNM treatment, did not result in any impairment in the functions such
as attachment and recognition of host cell receptors (as seen in the plaque assay - Tables 1
and 2). It could be postulated then that the change in the E proteins were so slight that the
proteins configurations were not affected to an extent which might affect recognition of
cellular receptors.
On the other hand, the maturation process of the viruses might not be a tightly controll-
ed system and would allow slight variability in the carbohydrate side chains on the viral
glycoproteins. The sugar moieties on these structural proteins (E and prM) did not appear
to play essential roles. In the formation of the mature virion of WN (Wengler) virus, the
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carbohydrate moiety of the precursor glycoproteins could be trimmed off before or during
the final maturation of virions. Such a cleavage probably would not depend on the presence
of unique oligosaccharides structure, as inhibition of glucose trimming by dNM does not af-
fect final maturation of the WN (Wengler) virus. Similar explanation was given by Wright (
1982) who worked on Kunjin virus (member of the West Nile subgroup) which showed that
Kunjin virus have the glycosylated E proteins only in the intracellular virus but not the ex-
tracellular particles.
The results obtained from the SDS-PAGE and plaque assays prompted further
analysis of the effect of dNM on the subcellular localisation of the E protein and the in-
tracellular transport of this protein. This was carried out with immunofluorescent technique
using anti-envelope serum, Con A and anti-Golgi serum. It was observed that dNM did not af-
fect the intracellular transport of the E proteins from the RER to the Golgi complex (Fig. 2
to 5). Thus, prevention of trimming of the outermost glucose moieties on the core oligosac-
charid Glc3 Man9 GlcNAc2 by dNM did not inhibit the transport of the envelope glycopro-
teins of WN viruses.
This result is in contrast to that obtained for vesicular stomatitis virus (Schlesinger et
al, 1984) but similar to that for haemagglutinin (HA) of influenza virus (Romero et al, 1983;
Burke et al, 1984), as well as for envelope glycoprotein of Rous sarcoma virus. This again
showed that the sugar moieties did not have a direct role in the recognition process by the
receptor proteins in Golgi complex during the trafficking of the E protein precursors. It
seems that both the WN (Sarafend) and the WN (Wengler) viruses follow the same glycosyla-
tion pathway from the RER to the Golgi complex in the infected Vero cells.
Another interesting observation from the autoradiograph was that the drug concentra-
tion at 2.5 mMappeared to have a greater effect on the WN (Wengler) virus infection com-
pared with 5 mM (Fig. 1, Lanes 5 and 6). This phenomenon was not observed with the WN
(Sarafend) virus. One possibility might be that 5 mM of the drug exceeded the ki (inhibition
constant) by two to three order of magnitude. This according to Fuhrmann and colleague
(1985) could lead to unreliable results.
From this study the conclusions are that both WN (Sarafend) and WN (Wengler)
viruses possess similar glycosylation pathway whereby the E proteins are transported from
the RER to the Golgi complex. The deoxynojirimycin does not affect the intracellular
transport of the E proteins. Therefore, prevention of removal of glucose molecules does not
affect the intracellular maturation of the E protein, showing that this process may not be
tightly controlled in the WN viruses. The presence of glucose residues in the high-mannose
oligosaccharide precursors of the E protein does not interfere with the maturation of the pro-
geny viruses.
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